BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2005;89:1184-1187; doi:10.1136/bjo.2005.067389
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krebs, I
Right arrow Articles by Goll, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krebs, I
Right arrow Articles by Goll, A

EXTENDED REPORT

Optical coherence tomography guided retreatment of photodynamic therapy

I Krebs1,2, S Binder1,2, U Stolba1,2, K Schmid2, C Glittenberg2, W Brannath3, A Goll3

1 Department of Ophthalmology Rudolf Foundation Clinic, Juchgasse 25, A-1030 Vienna, Austria
2 The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, Vienna, Austria
3 Department of Medical Statistics, University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Dr I Krebs
Department of Ophthalmology, Rudolf Foundation Clinic, Juchgasse 25, 1030 Vienna, Austria; Ilse.Krebs{at}wienkav.at

Aim: To evaluate the results of a retreatment modality of photodynamic therapy (PDT) based on optical coherence tomography (OCT) and fluorescein angiography (FA). To quantify the effect of PDT with the help of measurement of the retinal thickness.

Methods: Eyes with predominantly classic subfoveal choroidal neovascularisation (CNV) due to age related macular degeneration were included. PDT was performed every three months, when needed. OCT, FA, and measures of distance acuity were performed at baseline, after 6 weeks, 3 months, and from then on every 3 months. A control group of a consecutive series of eyes that had been retreated based only on FA results was installed.

Results: Forty eyes of 38 patients were included. The average age was 73 years. The maximum retinal thickness decreased from 404 µm at baseline to 281.6 µm at month 12. Furthermore there was a significant decrease of retinal thickness in both subgroups. The number of retreatments was reduced, when activity was diagnosed using OCT and FA. (2.4 v 4.0). The distance acuity correlated significantly with the maximum retinal thickness (p = 0.0042).

Conclusion: Information about the activity of a neovascular lesion can be obtained with the help of OCT. The retreatment modalities can be optimised by using OCT and FA and the number of retreatments can be reduced.


Abbreviations: CNV, choroidal neovascularisation; FA, fluorescein angiography; OCT, optical coherence tomography; PDT, photodynamic therapy; RPE, retinal pigment epithelium

Keywords: optical coherence tomography; photodynamic therapy; choroidal neovascularisation




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
T Moutray, M Alarbi, G Mahon, M Stevenson, and U Chakravarthy
Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation
Br. J. Ophthalmol., March 1, 2008; 92(3): 361 - 364.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
Z. F. Bashshur, A. Schakal, R. N. Hamam, C. P. El Haibi, R. F. Jaafar, and B. N. Noureddin
Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration
Arch Ophthalmol, October 1, 2007; 125(10): 1357 - 1361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.